Skip to main content

Table 2 Antibiotic susceptibility profiles of 43 GBS isolates from pregnant women

From: Analysis of virulence factors and antibiotic resistance genes in group B streptococcus from clinical samples

Antibiotic

 

MIC (μg/ml) c

 

Resistant no. (%)

Intermediate no. (%)

Susceptible no. (%)

MIC50

MIC90

Range

Disk diffusiona

 Penicillin G (10 units)

30/43 (69.8%)

0 (0%)

13/43 (30.2%)

d—

–

–

 Ampicillin (10 μg)

25/43 (58.1%)

0 (0%)

18/43 (41.9%)

–

–

–

 Tetracycline (30 μg)

42/43 (97.6%)

0 (0%)

1 (2.3%)

–

–

–

 Clindamycin (2 μg)

24/43 (55.8%)

11/43 (25.6%)

8/43 (18.6%)

–

–

–

 Erythromycin (15 μg)

13/43 (30.2%)

16/43 (37.2%)

14/43 (32.6%)

–

–

–

 Vancomycin (30 μg)

13/43 (30.2%)

0 (0%)

30/43 (69.8%)

–

–

–

 Cefazolin (30 μg)

31/43 (72.1%)

0 (0%)

12/43 (27.9%)

–

–

–

 Chloramphenicol (30 μg)

15/43 (34.9%)

16/43 (37.2%)

12/43 (27.9%)

–

–

–

 Ceftriaxone (30 μg)

20/43 (46.5%)

0 (0%)

23/43 (53.5%)

–

–

–

E-testb

 Ampicillin

20/43 (46.5%)

0 (0%)

23/43 (53.5%)

0.25

0.75

0.016 to 4

 Vancomycin

16/43 (37.2%)

0 (0%)

30/43 (63.7%)

1

4

0.25 to 8

 Chloramphenicol

0/43 (0%)

2/43 (4.7%)

12/43 (95.3%)

1.5

4

0 to 12

  1. a Testing was performed by disk diffusion
  2. b Testing was performed with E-test
  3. cMIC50 and MIC90, MICs at which 50 and 90% of isolates were inhibited, respectively
  4. d —, not available